Add this topic to your myFT Digest for news straight to your inbox
US healthcare company is putting cash to work from spinning off its consumer health arm
Ex-Tinder CEO Renate Nyborg thinks advanced AI can help
Research forecasts global deaths from the disease will almost double in 20 years
Outbreak kills at least one baby and is likely to worsen based on Dutch data
It aims to exploit its extraordinary cache of genetic data but changing corporate DNA is hard
WHO member states are struggling to agree the terms of the first global treaty to deal with the threat of another Covid-19
Jonathan Haidt argues that social media and gaming have disastrously rewired childhood, but haven’t we been here before?
The sixth annual ranking of companies in the region with the highest growth. Health tech businesses thrive post-pandemic even as VC funding drops. Plus: Singapore draws in start-ups; new models of corporate success in Japan; India’s EV expansion
Patients who took Sanofi’s lixisenatide experienced no worsening of motor symptoms
People (and fish) need to consume this seafood rather than wiping out stocks of the ‘big five’
Europe’s regulations have become ‘too burdensome’ and could hinder innovation, argues Michael Lohan
Widespread testing for this treatable if embarrassing condition is being hampered by lack of access to healthcare
Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating obesity-linked diseases
Party spearheads legislation as one lawmaker vows not to ‘eat bugs with Bill Gates’
Don’t milk this time for productivity gains or self-improvement — staring into space or a great book will be of more help
Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster
Aardvark Therapeutics’ drug has been shown in trials to suppress cravings in patients with rare genetic form of obesity
Justices’ scepticism towards disrupting the legal landscape is a potential boon for Republicans ahead of 2024 election
Ecommerce giant says it stands to generate ‘a lot of revenue’ from Eli Lilly’s Zepbound and similar treatments
In an age of remarkable scientific advances, three new books explore the prospects for living longer — and the challenges for human society
Transformative changes are still 10 to 15 years away, experts predict
How to protect your back, your mental health – and your job
Madrigal is the first to win approval for a treatment for a liver disease that affects one in 20
Chemotherapy can target microscopic cells to prevent the disease from spreading
Four years after lockdowns began we are still learning about pandemic hangovers
International Edition